ADAR1 Capital Management’s Kezar Life Sciences KZR Stock Holding History

ADAR1 Capital Management’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$608K	Sell	81,933 -35,507	-30%	-$231K	0.04%	194
2025 Q4	$739K	Sell	117,440 -7,527	-6%	-$43.9K	0.05%	159
2025 Q3	$487K	Sell	124,967 -22,437	-15%	-$92K	0.05%	137
2025 Q2	$675K	Hold	147,404	–	–	0.1%	102
2025 Q1	$719K	Hold	147,404	–	–	0.13%	89
2024 Q4	$991K	Buy	147,404 +13,577	+10%	+$101K	0.2%	77
2024 Q3	$1.03M	Buy	133,827 +25,177	+23%	+$152K	0.17%	74
2024 Q2	$652K	Buy	108,650 +84,988	+359%	+$646K	0.12%	85
2024 Q1	$213K	Buy	+23,662	New	+$216K	0.05%	117

Other funds holding KZR

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

ADAR1 Capital Management's KZR Position: Q1 2026 in Review

ADAR1 Capital Management reduced its Kezar Life Sciences (KZR) stake by 30% in Q1 2026, selling an estimated $231K and leaving 81,933 shares worth $608K. The position accounts for 0.04% of the portfolio, ranked #194.

ADAR1 Capital Management first reported a position in KZR in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.03M in Q3 2024. 43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

ADAR1 Capital Management held 81,933 shares of Kezar Life Sciences worth $608K as of Q1 2026.
ADAR1 Capital Management sold 35,507 Kezar Life Sciences shares in Q1 2026, an estimated $231K.
Kezar Life Sciences made up 0.04% of ADAR1 Capital Management's portfolio in Q1 2026, its #194 holding.
ADAR1 Capital Management first reported a position in Kezar Life Sciences in Q1 2024 and has held it in 9 quarters since.
ADAR1 Capital Management's Kezar Life Sciences position peaked at $1.03M in Q3 2024.
43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.